Chaikin P, Adir J
University of Medicine and Dentistry, New Jersey Medical School, Newark.
J Clin Pharmacol. 1987 Jan;27(1):70-3. doi: 10.1177/009127008702700111.
The pharmacokinetics of phenytoin was evaluated in a nonepileptic adult man after the ingestion of an undetermined amount of the drug following an apparent suicide attempt. A serum phenytoin concentration of 45 micrograms/mL was observed on admission 12 hours after ingestion. Phenytoin concentrations steadily increased, reached a maximum of 114 micrograms/mL four days later, then fluctuated at about 100 micrograms/mL for a week, and slowly declined to undetectable levels within the following week. At 96.5 micrograms/mL, the unbound serum concentration was 2.5 times that observed in therapeutic drug concentrations. Computer fitting of the data indicated that the Michaelis-Menten constants, apparent volume of distribution, and renal clearance of phenytoin were consistent with those parameters reported after therapeutic doses. However, phenytoin absorption was best described by parallel first- and zero-order rate processes, with the latter proceeding for as long as two weeks following drug ingestion. This protracted absorption appears to be a result of the presence of a large concretion of phenytoin in the gastrointestinal tract, having a slow disintegration and dissolution attributable to the limited solubility of the drug in the gastrointestinal tract and to the patient's diminished intestinal motility.
在一名非癫痫成年男性明显企图自杀并摄入未确定剂量的苯妥英后,对其苯妥英的药代动力学进行了评估。摄入后12小时入院时观察到血清苯妥英浓度为45微克/毫升。苯妥英浓度稳步上升,四天后达到最高值114微克/毫升,然后在约100微克/毫升波动一周,随后一周内缓慢下降至检测不到的水平。在96.5微克/毫升时,未结合血清浓度是治疗药物浓度时所观察到浓度的2.5倍。数据的计算机拟合表明,苯妥英的米氏常数、表观分布容积和肾清除率与治疗剂量后报告的参数一致。然而,苯妥英的吸收最好用平行的一级和零级速率过程来描述,后者在药物摄入后可持续长达两周。这种延长的吸收似乎是由于胃肠道中存在大量苯妥英结石,其缓慢崩解和溶解归因于药物在胃肠道中的溶解度有限以及患者肠道蠕动减弱。